Young‐Chul Kim

1993–2026 年に発表

別表記
Young Chul Kim · Young-Chul Kim
157
論文数
23,332
被引用数
62
h 指数
114
i10 指数

被引用数

Young‐Chul Kim の年別被引用数1993 年: 被引用 2 件1995 年: 被引用 5 件1997 年: 被引用 1 件1998 年: 被引用 3 件1999 年: 被引用 7 件2000 年: 被引用 2 件2001 年: 被引用 8 件2002 年: 被引用 4 件2003 年: 被引用 14 件2004 年: 被引用 5 件2005 年: 被引用 18 件2006 年: 被引用 40 件2007 年: 被引用 44 件2008 年: 被引用 37 件2009 年: 被引用 35 件2010 年: 被引用 35 件2011 年: 被引用 32 件2012 年: 被引用 30 件2013 年: 被引用 71 件2014 年: 被引用 102 件2015 年: 被引用 190 件2016 年: 被引用 259 件2017 年: 被引用 232 件2018 年: 被引用 370 件2019 年: 被引用 1,179 件2020 年: 被引用 1,404 件2021 年: 被引用 1,346 件2022 年: 被引用 1,025 件2023 年: 被引用 807 件2024 年: 被引用 1,261 件2025 年: 被引用 635 件2026 年: 被引用 20 件1994 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,028 件、この内訳の 22.5%中国: 引用元論文 2,558 件、この内訳の 19%イギリス: 引用元論文 646 件、この内訳の 4.8%日本: 引用元論文 625 件、この内訳の 4.7%イタリア: 引用元論文 612 件、この内訳の 4.6%ドイツ: 引用元論文 555 件、この内訳の 4.1%韓国: 引用元論文 530 件、この内訳の 3.9%フランス: 引用元論文 509 件、この内訳の 3.8%スペイン: 引用元論文 369 件、この内訳の 2.7%カナダ: 引用元論文 366 件、この内訳の 2.7%オランダ: 引用元論文 310 件、この内訳の 2.3%オーストラリア: 引用元論文 283 件、この内訳の 2.1%
0%22.5%その他 22.8%

分野

  • Medicine64.8%
  • Biochemistry, Genetics and Molecular Biology24.1%
  • Immunology and Microbiology3.3%
  • Computer Science2.3%
  • Engineering1.2%
  • Neuroscience0.9%
  • その他3.4%

トピック

  • Cancer Immunotherapy and Biomarkers9.7%
  • Lung Cancer Treatments and Mutations6.3%
  • Autophagy in Disease and Therapy3.9%
  • Lung Cancer Research Studies3.9%
  • Lung Cancer Diagnosis and Treatment3.8%
  • Hippo pathway signaling and YAP/TAZ2.4%
  • その他70%

共著者

全論文

検索で開く
  1. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 4,539

  2. mTOR: a pharmacologic target for autophagy regulation

    著者: , - Journal of Clinical Investigation 2015 被引用: 2,132

  3. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu - New England Journal of Medicine 2018 被引用: 2,800

  4. Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Josef Straub, Andreas Johne, J. Scheele, John V. Heymach, Xiuning Le - New England Journal of Medicine 2020 被引用: 854

  5. Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy

    著者: , , , , , , , , - Cell 2013 被引用: 783

  6. Metabolic Communication by SGLT2 Inhibition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Per Løgstrup Poulsen, Clarissa Schwab, Friederike Cuello, Volker Vallon, Markus M. Rinschen - Circulation 2023 被引用: 133

  7. Alternative Wnt Signaling Activates YAP/TAZ

    著者: , , , , , , , , , , , - Cell 2015 被引用: 745

  8. Explainable heat-related mortality with random forest and SHapley Additive exPlanations (SHAP) models

    著者: , - Sustainable Cities and Society 2022 被引用: 331

  9. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway

    著者: , , , , , , , - Nature Cell Biology 2015 被引用: 560

  10. Differential regulation of mTORC1 by leucine and glutamine

    著者: , , , , , , , - Science 2015 被引用: 754

  11. A role for tubular Na+/H+exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin

    著者: , , , , , , , , , , , , - American Journal of Physiology-Renal Physiology 2020 被引用: 202

  12. Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC

    著者: , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2021 被引用: 202

  13. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jian Fang, Wei Li, Jianying Zhou, Jun Zhao, Ying Cheng, Chih-Hsin Yang, Gee‐Chen Chang, Yuh‐Min Chen, Te‐Chun Hsia, Chih‐Feng Chian, Cheng-Ta Yang, Chin‐Chou Wang, Sang‐We Kim, Keunchil Park, Dong‐Wan Kim, Byoung Chul Cho, Ki Hyeong Lee, Young‐Chul Kim, Ho Jung An, In Sook Woo, Y. Choi, Sang Won Shin, Jong Seok Lee, Joo-Hang Kim, Seung Soo Yoo, Terufumi Kato, Naofumi Shinagawa, Ross A. Soo, Shao Weng Daniel Tan, Lynette Si-Mien Ngo, Kananathan Ratnavelu, Azura Rozila Ahmad, Chong Kin Liam, Filippo de Marinis, Pierfrancesco Tassone, Amelia Insa Molla, Antonio Calles, Martín Emilio Lázaro Quintela, Enriqueta Felip Font, Anne‐Marie C. Dingemans, Lynne A. Bui - The Lancet Respiratory Medicine 2020 被引用: 258

  14. Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K. Sabari, Angel Qin, Dariusz M. Kowalski, Mehmet Alı Nahıt Şendur, John Xie, Debopriya Ghosh, Ali Alhadab, Nahor Haddish‐Berhane, Pamela L. Clemens, Patricia Lorenzini, Remy B. Verheijen, Mohamed Gamil, Joshua Bauml, Mahadi Baig, Antonio Passaro, for the PALOMA-3 Investigators, Hiroaki Akamatsu, Mariam P. Alexander, Annalen Bleckmann, Federico Cappuzzo, Ying Cheng, Byoung Chul Cho, Timuçin Çil, Alexis B. Cortot, Pongwut Danchaivijitr, Till‐Oliver Emde, Dilek Erdem, Enriqueta Felip, F. Estevinho, Maria Lurdes Ferreira, Flavio Ferreira da Silva, Maria Campelo, Laurent Greillier, Alastair Greystoke, Ji‐Youn Han, Ping‐Chih Hsu, Jen‐Yu Hung, Mei Ji, Thomas John, Rohit Joshi, Young‐Chul Kim, Masashi Kondo, Ernesto Korbenfeld, Dariusz M. Kowalski, Se‐Hoon Lee, Natasha B. Leighl, Juan Li, Sheng-Hao Lin, Baogang Liu, Caigang Liu, John Seng-Hooi Low, Melina E. Marmarelis, Bartomeu Massutí, Anna R. Minchom, Sara Moore, Mor Moskovitz, Adnan Nagrial, Danny Nguyen, Silvia Novello, Y. Ohe, Mustafa Özgüroğlu, Özgür Özyılkan, Antonio Passaro, Nir Peled, Naiyarat Prasongsook, Angel Qin, Elisa F. Ramos ほか 22 名 - Journal of Clinical Oncology 2024 被引用: 114

  15. Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes

    著者: , , , , , - Clinical Cancer Research 2015 被引用: 875

  16. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Veerle Surmont, Martin Reck, Ji‐Youn Han, Esther Holgado Martin, Cristóbal Belda-Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, G. Robinet, Héctor Soto Parrà, Michael J. Thomas, Parneet Cheema, Nobuyuki Katakami, Wu‐Chou Su, Young‐Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Stanislaw Milella, Inmaculada Ramos García, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, E. Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Rémi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan M. Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoîne Italiano, Dariusz M. Kowalski, Fabrice Barlési, Yuh‐Min Chen, David R. Spigel, Busyamas Chewaskulyong, Ramón García Gómez, Rosa Álvarez, Chih-Hsin Yang, Te‐Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Kōichi Goto, Joaquim Bosch‐Barrera, Glen J. Weiss, Jean-Luc Canon, Christian W. Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope A. Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn A. Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius F. Waller, David Waterhouse, Bruno Coudert, Z. Mark ほか 52 名 - The Lancet Oncology 2018 被引用: 576

  17. KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation.

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 70

  18. ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC).

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 57

  19. Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP

    著者: , , , , , , , , , , , , , , , , - Cancer Cell 2014 被引用: 458

  20. Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors

    著者: , , , , , , , , , , , - Immune Network 2020 被引用: 76

  21. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tongwu Zhang, Charles E. Breeze, Zhaoming Wang, Batel Blechter, Bryan A. Bassig, Jin Hee Kim, Demetrius Albanes, Jason Y.Y. Wong, Min‐Ho Shin, Lap Ping Chung, Yang Yang, Shejuan An, Hong Zheng, Yasushi Yatabe, Xu‐Chao Zhang, Young‐Chul Kim, Neil E. Caporaso, Jiang Chang, Jcm Ho, Michiaki Kubo, Yataro Daigo, Minsun Song, Yukihide Momozawa, Yoichiro Kamatani, Masashi Kobayashi, Kenichi Okubo, Takayuki Honda, Dean Hosgood, Hideo Kunitoh, Harsh Patel, Shun‐ichi Watanabe, Yohei Miyagi, Haruhiko Nakayama, Shingo Matsumoto, Hidehito Horinouchi, Masahiro Tsuboi, Ryuji Hamamoto, Kōichi Goto, Yuichiro Ohe, Atsushi Takahashi, Akiteru Goto, Yoshihiro Minamiya, Megumi Hara, Yuichiro Nishida, Kenji Takeuchi, Kenji Wakai, Koichi Matsuda, Yoshinori Murakami, Kimihiro Shimizu, Hiroyuki Suzuki, Motonobu Saito, Yoichi Ohtaki, Kazumi Tanaka, Tangchun Wu, Fusheng Wei, Hong Dai, Mitchell J. Machiela, Jian Su, Yeul Hong Kim, In‐Jae Oh, Victor Lee, Gee‐Chen Chang, Ying‐Huang Tsai, Kuan‐Yu Chen, Ming‐Shyan Huang, Wu‐Chou Su, Yuh‐Min Chen, Adeline Seow, Jae Yong Park, Sun‐Seog Kweon ほか 122 名 - Nature Communications 2023 被引用: 70

  22. Sestrins Inhibit mTORC1 Kinase Activation through the GATOR Complex

    著者: , , , , , , , , - Cell Reports 2014 被引用: 326

  23. Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic Correlation

    著者: , , , , , , , , - Radiographics 2009 被引用: 449

  24. Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Myung‐Ju Ahn, Gad Getz, Matthew Meyerson, Keunchil Park - Journal of Clinical Oncology 2013 被引用: 204